These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2250 related articles for article (PubMed ID: 7881635)

  • 21. Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancement.
    Xu Q; Shao J; Su S; Wei J; Chen F; Meng F; Zhao Y; Du J; Zou Z; Qian X; Liu B
    Cell Immunol; 2018 Sep; 331():1-8. PubMed ID: 29903664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes.
    Arienti F; Sulé-Suso J; Melani C; Maccalli C; Belli F; Illeni MT; Anichini A; Cascinelli N; Colombo MP; Parmiani G
    Hum Gene Ther; 1994 Sep; 5(9):1139-50. PubMed ID: 7833372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.
    Lotze MT; Zeh HJ; Elder EM; Cai Q; Pippin BA; Rosenstein MM; Whiteside TL; Herberman R
    J Immunother (1991); 1992 Oct; 12(3):212-7. PubMed ID: 1359903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and functional characteristics of tumor-infiltrating lymphocytes from human colorectal cancers after stimulation with rIL-2.
    Keller H; Wimmenauer S; Rahner S; Reimer P; von Kleist S; Farthmann EH
    Eur Surg Res; 1995; 27(4):258-68. PubMed ID: 7649213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
    Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
    J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.
    Miller AR; McBride WH; Dubinett SM; Dougherty GJ; Thacker JD; Shau H; Kohn DB; Moen RC; Walker MJ; Chiu R
    Blood; 1993 Dec; 82(12):3686-94. PubMed ID: 8260705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.
    Merrouche Y; Negrier S; Bain C; Combaret V; Mercatello A; Coronel B; Moskovtchenko JF; Tolstoshev P; Moen R; Philip T
    J Clin Oncol; 1995 Feb; 13(2):410-8. PubMed ID: 7844602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
    Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.
    Saint-Jean M; Knol AC; Volteau C; Quéreux G; Peuvrel L; Brocard A; Pandolfino MC; Saiagh S; Nguyen JM; Bedane C; Basset-Seguin N; Khammari A; Dréno B
    J Immunol Res; 2018; 2018():3530148. PubMed ID: 29750176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.
    Rosenberg SA; Yannelli JR; Yang JC; Topalian SL; Schwartzentruber DJ; Weber JS; Parkinson DR; Seipp CA; Einhorn JH; White DE
    J Natl Cancer Inst; 1994 Aug; 86(15):1159-66. PubMed ID: 8028037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.
    Steger GG; Kaboo R; deKernion JB; Figlin R; Belldegrun A
    Br J Cancer; 1995 Jul; 72(1):101-7. PubMed ID: 7599037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro.
    Noguchi K; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Tani M; Mizobata S; Hotta T; Arii K; Tamai M
    Anticancer Res; 1995; 15(2):255-8. PubMed ID: 7762991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
    Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
    Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells.
    Tanaka Y; Mine S; Hanagiri T; Hiraga T; Morimoto I; Figdor CG; van Kooyk Y; Ozawa H; Nakamura T; Yasumoto K; Eto S
    Cancer Res; 1998 Sep; 58(18):4138-45. PubMed ID: 9751626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.
    Hayakawa K; Salmeron MA; Parkinson DR; Markowitz AB; von Eschenbach AC; Legha SS; Balch CM; Ross MI; Augustus LB; Itoh K
    J Immunother (1991); 1991 Oct; 10(5):313-25. PubMed ID: 1790139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytological characteristics of human glioma-infiltrating lymphocytes stimulated with recombinant interleukin 2 and an anti-CD3 antibody.
    Kikuchi T; Watanabe M; Ohno T
    Jpn J Cancer Res; 1991 Mar; 82(3):339-45. PubMed ID: 1827092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.
    Steger GG; Pierce WC; Figlin R; Czernin J; Kaboo R; DeKernion JB; Okarma T; Belldegrun A
    Clin Immunol Immunopathol; 1994 Aug; 72(2):237-47. PubMed ID: 8050198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
    Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
    J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growth in vitro.
    Darrow TL; Wahab Z; Quinn-Allen MA; Seigler HF
    Cancer; 1992 Apr; 69(7):1843-9. PubMed ID: 1532342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 113.